| CAS ID: | 137945-48-3 |
| Molecular Formula: | C25H36O4 |
| Molecular Weight: | 400.6 g/mol |
| Monoisotopic Mass: | 400.2614 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LENABASUM | Ajulemic Acid | IP-751 | CT-3 | JBT-101 | CPL7075 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C25H36O4/c1-6-7-8-9-12-24(2,3)17-14-20(26)22-18-13-16(23(27)28)10-11-19(18)25(4,5)29-21(22)15-17/h10,14-15,18-19,26H,6-9,11-13H2,1-5H3,(H,27,28)/t18-,19-/m1/s1 | See All |
| InChI Key: | YCHYFHOSGQABSW-RTBURBONSA-N | |
| Smiles: | CCCCCCC(C)(C)c1cc(O)c2[C@@H]3CC(=CC[C@H]3C(C)(C)Oc2c1)C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02465450 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | June 8, 2015 | Last Verified | April 4, 2018 |
| Sponsor | Corbus Pharmaceuticals Inc. | ||
| PubChem: | 3083542 |
| ChEMBL: | CHEMBL456341 |